-
Something wrong with this record ?
IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction
J. Prochazkova, K. Pokorna, V. Holan,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Cell Differentiation drug effects immunology MeSH
- Th17 Cells cytology drug effects immunology metabolism MeSH
- Gene Expression drug effects immunology MeSH
- Forkhead Transcription Factors genetics immunology metabolism MeSH
- Interferon-gamma genetics immunology metabolism MeSH
- Interleukin-12 immunology pharmacology MeSH
- Interleukin-2 genetics immunology metabolism MeSH
- Interleukin-6 genetics immunology metabolism MeSH
- Nuclear Receptor Subfamily 1, Group F, Member 3 genetics immunology metabolism MeSH
- Macrophages cytology drug effects immunology MeSH
- Mice, Inbred BALB C MeSH
- Mice MeSH
- Nitric Oxide biosynthesis MeSH
- Receptors, CCR5 genetics immunology metabolism MeSH
- Receptors, Interleukin-18 genetics immunology metabolism MeSH
- T-Lymphocytes, Regulatory cytology drug effects immunology metabolism MeSH
- Signal Transduction drug effects immunology MeSH
- Th1 Cells cytology drug effects immunology metabolism MeSH
- Transforming Growth Factor beta immunology pharmacology MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The development and differentiation of T helper (Th) cell subsets is a highly plastic process which is strictly regulated by cytokines. Here we show that the transforming growth factor β (TGF-β)-dependent differentiation programs are negatively regulated by interleukin-12 (IL-12). The development of TGF-β-induced regulatory T cells (iTregs) or TGF-β/IL-6 activated Th17 cells from purified mouse CD4(+)CD25(-) T cells, stimulated with monoclonal antibody anti-CD3, was abrogated in the presence of IL-12 and a different developmental program was established. On the molecular level, IL-12 inhibited the expression of the lineage specific transcription factors Foxp3 and RORγt in developing Tregs and Th17 cells, respectively. Moreover, IL-12 was able to alter the development of iTregs and Th17 cells even when added to the differentiating cells after 48h of the culture. The cells activated in the presence of TGF-β and IL-12 had an increased expression of the Th1 transcription factor T-bet, produced Th1 cytokines interferon γ and IL-2 and expressed IL-18 receptor and C-C chemokine receptor type 5 which are the phenotypic markers characteristic for Th1 cells. Furthermore, the cells activated in the presence of both TGF-β and IL-12, and not of TGF-β only, stimulated macrophages to produce nitric oxide. Altogether, these results indicate that IL-12 is a superior cytokine that has the ability to skew the already ongoing TGF-β-dependent iTreg or Th17 developmental program into Th1-like direction.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024367
- 003
- CZ-PrNML
- 005
- 20121207110331.0
- 007
- ta
- 008
- 120815s2012 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.imbio.2011.07.032 $2 doi
- 035 __
- $a (PubMed)21903294
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Prochazkova, Jana $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague 4, Czech Republic.
- 245 10
- $a IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction / $c J. Prochazkova, K. Pokorna, V. Holan,
- 520 9_
- $a The development and differentiation of T helper (Th) cell subsets is a highly plastic process which is strictly regulated by cytokines. Here we show that the transforming growth factor β (TGF-β)-dependent differentiation programs are negatively regulated by interleukin-12 (IL-12). The development of TGF-β-induced regulatory T cells (iTregs) or TGF-β/IL-6 activated Th17 cells from purified mouse CD4(+)CD25(-) T cells, stimulated with monoclonal antibody anti-CD3, was abrogated in the presence of IL-12 and a different developmental program was established. On the molecular level, IL-12 inhibited the expression of the lineage specific transcription factors Foxp3 and RORγt in developing Tregs and Th17 cells, respectively. Moreover, IL-12 was able to alter the development of iTregs and Th17 cells even when added to the differentiating cells after 48h of the culture. The cells activated in the presence of TGF-β and IL-12 had an increased expression of the Th1 transcription factor T-bet, produced Th1 cytokines interferon γ and IL-2 and expressed IL-18 receptor and C-C chemokine receptor type 5 which are the phenotypic markers characteristic for Th1 cells. Furthermore, the cells activated in the presence of both TGF-β and IL-12, and not of TGF-β only, stimulated macrophages to produce nitric oxide. Altogether, these results indicate that IL-12 is a superior cytokine that has the ability to skew the already ongoing TGF-β-dependent iTreg or Th17 developmental program into Th1-like direction.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a buněčná diferenciace $x účinky léků $x imunologie $7 D002454
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a forkhead transkripční faktory $x genetika $x imunologie $x metabolismus $7 D051858
- 650 _2
- $a exprese genu $x účinky léků $x imunologie $7 D015870
- 650 _2
- $a interferon gama $x genetika $x imunologie $x metabolismus $7 D007371
- 650 _2
- $a interleukin-12 $x imunologie $x farmakologie $7 D018664
- 650 _2
- $a interleukin-2 $x genetika $x imunologie $x metabolismus $7 D007376
- 650 _2
- $a interleukin-6 $x genetika $x imunologie $x metabolismus $7 D015850
- 650 _2
- $a makrofágy $x cytologie $x účinky léků $x imunologie $7 D008264
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a oxid dusnatý $x biosyntéza $7 D009569
- 650 _2
- $a jaderné receptory - podrodina 1, skupina F, člen 3 $x genetika $x imunologie $x metabolismus $7 D057132
- 650 _2
- $a receptory CCR5 $x genetika $x imunologie $x metabolismus $7 D019713
- 650 _2
- $a receptory interleukinu-18 $x genetika $x imunologie $x metabolismus $7 D053724
- 650 _2
- $a signální transdukce $x účinky léků $x imunologie $7 D015398
- 650 _2
- $a regulační T-lymfocyty $x cytologie $x účinky léků $x imunologie $x metabolismus $7 D050378
- 650 _2
- $a Th1 buňky $x cytologie $x účinky léků $x imunologie $x metabolismus $7 D018417
- 650 _2
- $a buňky Th17 $x cytologie $x účinky léků $x imunologie $x metabolismus $7 D058504
- 650 _2
- $a transformující růstový faktor beta $x imunologie $x farmakologie $7 D016212
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pokorna, Katerina
- 700 1_
- $a Holan, Vladimir
- 773 0_
- $w MED00002188 $t Immunobiology $x 1878-3279 $g Roč. 217, č. 1 (2012), s. 74-82
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21903294 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20121207110405 $b ABA008
- 999 __
- $a ok $b bmc $g 946515 $s 781695
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 217 $c 1 $d 74-82 $i 1878-3279 $m Immunobiology $n Immunobiology $x MED00002188
- LZP __
- $a Pubmed-20120815/12/02